Sanjiv S. Agarwala, MD | Authors

Dr Antonio Jorge salomao

R Barata Ribeiro 490 cj 11

São Paulo



The Role of Intralesional Therapies in Melanoma

May 15, 2016

Through the emergence of new immunotherapies, treatment of melanoma is undergoing a long-awaited revolution. Ongoing research will clarify the outlines of the place that intralesional therapies will occupy in the therapeutic armamentarium in the years ahead.

Update on Adjuvant Interferon Therapy for High-Risk Melanoma

September 01, 2002

Melanoma is almost 100% curable when diagnosed early, but when metastatic to distant organs, it is associated with a poor survival. The interferons have shown the most promise in the treatment of melanoma and interferon